Value-Based Healthcare Is So 2015. Now Products Are the Talk of Medtech

Posted by Brian Chapman on March 20, 2019

For as long as I can remember, value-based healthcare has been the talk of the medtech industry, and for good reason: Who can argue with efforts to improve patient outcomes at a lower cost? With such virtuous and unassailable aims, it’s the irresistible force that dominated strategies in the last decade.


>
Read More

Into 2019: Risk, Uncertainty and a Return to Product Focus

Posted by Brian Chapman on January 23, 2019

Looking ahead to what the medtech industry can expect in 2019, I see a continuation of some of the greatest accomplishments of 2018, such as ongoing collaboration with regulatory bodies and real-world evidence driving more reimbursement discussions, as well as the brave new world of digital health continuing to buoy how our industry can help patients.


>
Read More

Vital Signs: How Medtech Companies Can Heal the Aches and Pains of Modern Healthcare Systems

Posted by Will Randall on November 15, 2018

Hospital spending has grown 15% and patient admissions are up 20% since 2009. Despite some efficiency gains, the provider financial deficit is large and growing, and patients are waiting longer than ever before for treatment in a system stretched to capacity. Sound familiar?


>
Read More

Oil Changes and Knee Replacements: Healthcare’s Shift to Lower-Cost Care

Posted by Prateek Harsh on November 5, 2018

As the final speaker of the day shared his closing thoughts at Becker’s ASC Annual Meeting, held Oct. 18-20 in Chicago, one thing was clearer to me than ever before: Healthcare delivery is finally starting to operate like a “business” similar to what you’d typically expect with most other industries in a free-market model. And ASCs—ambulatory surgery centers—come closest to the free-market model in healthcare. Consumers often are paying a big chunk out of pocket for their treatment and, as a result, shop around for the best price and quality. Similarly, providers are competing to drive efficiency while maintaining costs. With the help of these forces, ASCs are ripe for growth. 


>
Read More

Medtech Companies Need to be Solutions-Oriented, not Product-Driven

Posted by Rohan Agni on October 18, 2018

The vice president of supply chain at a top IDN system recently told me, “In medtech, there is no evidence-based information whatsoever that one manufacturer is better than another. Take CRM, for example. There are three top players, but there’s no evidence that any one pacemaker is better than the others."


>
Read More